Opens in a new tab

F. Hoffmann-La Roche v A. Menarini Diagnostics (CFI, 1 October 2025)

Date1 October 2025
CourtCFI
DivisionDüsseldorf (DE) Local Division
Type of actionApplication RoP262A
Case number(s)UPC_CFI_712/2025
Registry referenceUPC_CFI_712/2025
PartiesF. Hoffmann-La Roche AG a.o. v. A. Menarini Diagnostics S.r.l. a.o.

Official decision (PDF) · UPC registry entry

Case timeline

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

In an order of 1 October 2025 (UPC_CFI_712/2025), issued in German, the Düsseldorf Local Division protected under Rule 262A the confidential information contained in the objection filed on 23 September 2025 by the Menarini companies against Roche (EP 1 962 668): the manufacturing process of the accused products, negotiations with the manufacturer Sinocare, prices and margins, and the unredacted versions of three written witness statements. The order was uncontested. Its interest lies in the clarification given for knowledge acquired outside the proceedings.

Question

Which information in the objection should be restricted to a limited circle, and how should persons who already knew of it be treated?

Decision

The formal requirements of Rules 262A.2 and 262A.3 were met and the applicants’ representatives were heard (paragraph 2), they did not contest the classification (paragraph 3), and the parties agreed on the circle of authorised persons (paragraph 5). On Roche’s side, access is limited to representatives, witnesses and experts and to four named members of its in-house IP teams, and the duty of confidentiality survives the proceedings. The division clarified that the bar on use does not cover information already known to certain persons outside the proceedings (paragraph 6), and left the hearing, the decision and third-party access to be addressed later (paragraph 7). Any culpable breach may attract a penalty payment.

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Art. 58
Rules of Procedure
Rules 262.2 and 262A
Other provisions
Directive (EU) 2016/943, Art. 9(1) and (2)(a)

Related decisions

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Decisions in the same proceedings

Going further

Lexicon: Confidentiality club.

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

  • UPC_CFI_712/2025 official number

Follow this case

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

  1. 1 October 2025 F. Hoffmann-La Roche v A. Menarini Diagnostics (CFI, 1 October 2025) Application RoP262A · UPC_CFI_712/2025
  2. 5 December 2025 F. Hoffmann-La Roche v A.Menarini Diagnostics (CFI, 5 December 2025) Application for provisional measures · UPC_CFI_712/2025

    La demande est accueillie pour l'essentiel : la contrefaçon littérale des revendications 1 et 16 est suffisamment certaine, la validité suffisamment assurée et l'urgence établie, la division prononce une injonction couvrant la fabrication, la remise des produits à un huissier et des informations, sans garantie, les fra…

  3. 11 March 2026 A. Menarini Diagnostics v F. Hoffmann-La Roche (CoA, 11 March 2026) Appeal RoP220.1 · appeal, first-instance number cited in the decision

    La cour d'appel autorise le désistement de la demande de mesures provisoires de Roche après transaction, déclare la procédure close, annule l'audience du 18 juin 2026 et ne statue pas sur les frais, conformément à l'accord des parties.

What the record states

Nature of the act
Application RoP262A
Outcome (Dhenne Avocats summary)
La division réserve à un cercle restreint les informations confidentielles de l'opposition des défenderesses, avec l'accord des parties, et précise que l'interdiction d'usage ne vise pas les informations déjà connues hors de la procédure.
Appeal
An appeal is documented in the corpus (see above).
Instance
First-instance decision, whether it has become final is not recorded.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 1 962 668Mentioned in the analysis (role not qualified)
Also mentioned in 3 other decision(s): F. Hoffmann-La Roche v A. Menarini Diagnostics (CFI, 25 March 2026) · A. Menarini Diagnostics v F. Hoffmann-La Roche (CoA, 11 March 2026) · F. Hoffmann-La Roche v A.Menarini Diagnostics (CFI, 5 December 2025)
not recordednot recordednot recordedEspacenet
links not checked
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.